The Next Food Pyramid: Lab-Grown Meat and the New Moral Orthodoxy

The honest version of this history is not that Seventh-day Adventists single-handedly invented the USDA’s 1992 Food Guide Pyramid. It is that they helped build the moral, institutional, and research ecosystem in which anti-meat ideas could move from sectarian conviction to nutrition orthodoxy. Adventism explicitly linked theology and food to encourage vegetarianism, and its health institutions helped pioneer breakfast cereals and meat analogues. Over time, Adventist researchers secured NIH funding, and major studies of Adventist populations contributed “greatly” to the broader understanding of nutrition and health.

That influence was not merely academic. Loma Linda researchers published a “vegetarian food guide pyramid” in 1999, explicitly presenting a new pyramid-shaped guide built around plant foods and introduced through the Third International Congress on Vegetarian Nutrition. Their stated aim was to stop treating vegetarian guidance as a mere adaptation of the ordinary omnivorous guide and instead create a new framework centered on vegetarian dietary patterns. That does not prove the federal pyramid was an Adventist artifact. It does show that Adventist institutions were actively translating a long-standing anti-meat moral vision into the same visual and policy language that official nutrition used.

And the official pyramid, of course, did not age well. Harvard’s Nutrition Source says the original 1992 Food Guide Pyramid “conveyed the wrong dietary advice”: too much emphasis on grains without distinguishing refined from whole grains, and a crude anti-fat message that obscured the difference between beneficial oils and harmful dietary patterns. The USDA itself eventually moved on, replacing the pyramid with MyPlate in 2011. That is the point worth remembering. When public authority hardens a fashionable dietary theory into bureaucracy, the errors do not stay private. They become school lunches, subsidies, procurement rules, educational materials, and years of institutional inertia.

None of this means every Adventist finding was false. Quite the opposite: even critics should admit that Adventist cohorts generated important hypotheses and useful observations. But even friendly reviews acknowledge the limits of the evidence. Adventist-associated authors note that cohort studies are not strong for proving relationships, only associations, and Walter Willett’s review of Adventist studies emphasized that important questions remained unresolved even while praising the value of the research program. That is precisely why moral enthusiasm should not be allowed to skip over scientific humility and land directly in state policy.

Now watch the same pattern repeat with cultivated meat. The Good Food Institute openly says it works with governments to advocate public investment in alternative proteins, while New Harvest says that “publicly-funded groups like ours” are needed to steer cellular agriculture toward the public good. By GFI’s own 2024 policy report, governments were estimated to disburse about $560 million on alternative proteins in 2024, with cultivated meat alone drawing $84 million in public investment that year, double the previous high. In the United States, USDA already put a historic $10 million grant into Tufts’ National Institute for Cellular Agriculture, where the research agenda includes consumer acceptance, willingness-to-pay, scalable cell lines, serum-free media, scaffolds, and process optimization.

That is not a picture of a market proving itself. It is a picture of advocates trying to socialize the cost of proving whether a market exists. GFI’s 2024 industry report says privately-held cultivated-meat companies raised $139 million in 2024, after a much hotter funding environment in prior years, and then argues that companies will need governments, philanthropists, and investors to develop new funding solutions because there are “no silver bullets” for the sector’s funding gap. Translation: when private capital gets cautious, the pressure shifts to the taxpayer. The state becomes the venture capitalist of last resort for a technology whose commercial viability remains unresolved enough that federally-funded researchers are still studying whether consumers will even pay for it.

And then comes the truly grotesque frontier: “bodyoids.” In 2025, proponents argued that brainless human or nonhuman bodies grown for instrumental use could relieve organ shortages, reduce animal experimentation, and even provide “meat or other products with no animal suffering or awareness.” Yet a later philosophical commentary on the proposal concluded that human bodyoids are “technically remote, economically untenable, and ethically troubling.” That combination should set off every alarm. When a proposal is biologically speculative, economically absurd, and ethically radioactive, the one thing government should not do is create a grant program for it.

I have not found evidence of a dedicated public bodyoid-funding pipeline yet. But that is not reassuring. It is simply the stage before the pitch deck. The moral rhetoric is already in place: reduce suffering, replace animals, solve shortages, modernize medicine. We have already watched adjacent advocacy groups build the case that alternative-protein research deserves public subsidy, public institutions, and public legitimacy. It takes very little imagination to see the same lobbying grammar being deployed for ever more speculative bio-industrial fantasies.

The libertarian lesson is straightforward. Let ethical vegans, animal-rights philanthropists, and true believers fund these projects voluntarily. Let investors bear the downside if the numbers never work. Let consumers decide whether the products deserve a market. But do not compel the public to finance a new generation of laboratory crusades merely because they are wrapped in the language of compassion, sustainability, and innovation. The lesson of the food-pyramid era is not that vegetarianism is worthless. It is that once a moralized diet theory captures expert prestige and state machinery, bad science becomes public policy, and taxpayers are forced to pay for both the mistake and the cleanup.